Photodynamic Therapy in Treating Patients With Early Esophageal Cancer

Completed · Phase 2

Conditions studied: Esophageal Cancer

In brief

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. This may be an effective treatment for esophageal cancer. PURPOSE: Phase II trial to study the effectiveness of photodynamic therapy in treating patients with Barrett's esophagus who have in situ esophageal cancer.

Key facts

Study ID

NCT00002935

Run by

Roswell Park Cancer Institute

People needed

30

Starts

1995-10-01

Expected to finish

2007-09-01

Last updated by the study team

2011-12-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Roswell Park Cancer Institute — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.